speb/financial-data huggingface dataset:
Financial ratios for GNTX — quarterly report dated 2025-06-30
Total revenue: 657858210
Gross profit: 225290903
Operating income: 125304271
Net income: 96039584
Capital expenditures: 30919826
Operating cash flow: 166139351
Depreciation & amortization: 27371374
Net tangible assets: 1819799346
Owner earnings: 92491132
Return on net tangible assets (%): 5.082490671474282
Capex to operating income (%): 24.67579576756805
Buffett classification: The Great
Stock price: 21.44
P/E ratio: 11.884910968377373
Shares outstanding: 212951848
Book value: 2433127985
P/B ratio: 1.8764683359309602
Market cap (USD): 4565687621.12
Debt to equity: 0.001616231050829823
Current ratio: 3.1518844981640535
Quick ratio: 1.7399763689529992
Effective tax rate (%): 17.164341509972548
COGS to revenue (%): 65.75388137209688
R&D to revenue (%): 7.8240685025425165
SG&A to revenue (%): 7.37474341165401
Free cash flow (dilution-adjusted): 127539004
Buyback yield (%): 2.8700270336903975
Retained earnings: 1421351763
Inventory turnover: 0.9092903670874752
Receivables turnover: 1.763875628556683
Capitalized R&D asset: 82240600.88
ROCI (R&D-adjusted, %): 5.639051889630312
Rosenberg metric: 0.7307083447034781
FCF margin (%): 19.38700499002665
Revenue growth (%): 14.058409001016328
Rule of 40 score: 33.445413991042976
Financial ratios for GNTX — quarterly report dated 2025-09-30
Total revenue: 655236055
Gross profit: 225166737
Operating income: 122845128
Net income: 100967910
Capital expenditures: 35570609
Operating cash flow: 146982701
Depreciation & amortization: 25928524
Net tangible assets: 1864448774
Owner earnings: 91325825
Return on net tangible assets (%): 4.898274829190882
Capex to operating income (%): 28.955653007256423
Buffett classification: The Good
Stock price: 27.74
P/E ratio: 20.23863613902625
Shares outstanding: 212951848
Book value: 2497534484
P/B ratio: 2.365246326472744
Market cap (USD): 5907284263.5199995
Debt to equity: 0.0016539747604942378
Current ratio: 2.9622397013788824
Quick ratio: 1.696589481414933
Effective tax rate (%): 16.325693301892198
COGS to revenue (%): 65.6357834276992
R&D to revenue (%): 8.032938144711832
SG&A to revenue (%): 7.583053713367467
Free cash flow (dilution-adjusted): 100961690
Buyback yield (%): 0.5104443709643383
Retained earnings: 1471866630
Inventory turnover: 0.8614418027617311
Receivables turnover: 1.7033548647429595
Capitalized R&D asset: 102275502.71000001
ROCI (R&D-adjusted, %): 4.7408356056534515
Rosenberg metric: -0.0024123357188126494
FCF margin (%): 15.40844543421836
Revenue growth (%): -0.3985896900184616
Rule of 40 score: 15.009855744199898
Financial ratios for GNTX — quarterly report dated 2025-12-31
Total revenue: 644401610
Gross profit: 224517713
Operating income: 121554875
Net income: 93270878
Capital expenditures: 17521132
Operating cash flow: 125498718
Depreciation & amortization: 25232797
Net tangible assets: 1859921267
Owner earnings: 100982543
Return on net tangible assets (%): 5.429398802610713
Capex to operating income (%): 14.414174668025451
Buffett classification: The Great
Stock price: 22.91
P/E ratio: 12.66700304175944
Shares outstanding: 212951848
Book value: 2490931937
P/B ratio: 1.9585950002133679
Market cap (USD): 4878726837.68
Debt to equity: 0.001523897519484893
Current ratio: 2.9117660705128157
Quick ratio: 1.5796463875467703
Effective tax rate (%): 16.269377415042854
COGS to revenue (%): 65.15872873129538
R&D to revenue (%): 8.2602847624791
SG&A to revenue (%): 7.717769358149183
Free cash flow (dilution-adjusted): 89775644
Buyback yield (%): 1.7725094451306114
Retained earnings: 1466046002
Inventory turnover: 0.8133287267602815
Receivables turnover: 1.7486319899174196
Capitalized R&D asset: 105480183.1
ROCI (R&D-adjusted, %): 4.622624724067018
Rosenberg metric: -0.012330723148131138
FCF margin (%): 13.931629376282906
Revenue growth (%): -1.653517830303157
Rule of 40 score: 12.27811154597975
Financial ratios for GNTX — annual report dated 2025-12-31
Total revenue: 2534268965
Gross profit: 866708940
Operating income: 485580492
Net income: 384841367
Capital expenditures: 120680858
Operating cash flow: 587126291
Depreciation & amortization: 104041764
Net tangible assets: 1859921267
Owner earnings: 368202273
Return on net tangible assets (%): 19.79665911309782
Capex to operating income (%): 24.852904922712586
Buffett classification: The Great
Stock price: 22.91
P/E ratio: 12.677241211649681
Shares outstanding: 212951848
Book value: 2490931937
P/B ratio: 1.9585950002133679
Market cap (USD): 4878726837.68
Debt to equity: 0.001523897519484893
Current ratio: 2.9117660705128157
Quick ratio: 1.5796463875467703
Effective tax rate (%): 16.566160136909012
COGS to revenue (%): 65.80043586652216
R&D to revenue (%): 8.02044924225318
SG&A to revenue (%): 7.018540433414494
Free cash flow (dilution-adjusted): 421387695
Buyback yield (%): 6.4668400075875265
Retained earnings: 1466046002
Inventory turnover: 3.230117853101647
Receivables turnover: 6.876928478272904
Capitalized R&D asset: 375786855.07
ROCI (R&D-adjusted, %): 17.455280195495984
Rosenberg metric: 0.5268970026491936
FCF margin (%): 16.62758376556136
Revenue growth (%): 9.551431418032026
Rule of 40 score: 26.179015183593386
Financial ratios for HEVI.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -37500
Operating income: -4611764.705882353
Net income: -5413970.5882352935
Capital expenditures: 4497058.823529411
Operating cash flow: -1061029.4117647058
Depreciation & amortization: 37500
Net tangible assets: 9408823.529411765
Owner earnings: -9873529.411764704
Return on net tangible assets (%): -104.93904345107843
Buffett classification: The Gruesome
Stock price: 0.1691176470588235
Shares outstanding: 163013796
Book value: 9408823.529411765
P/B ratio: 2.9300697936855262
Market cap (USD): 27568509.617647056
Debt to equity: 0.002266333229134104
Current ratio: 56.934426229508205
Quick ratio: 56.934426229508205
Free cash flow (dilution-adjusted): -5944852.94117647
Buyback yield (%): 0
Retained earnings: -6452205.882352941
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -48.85115663213646
Rule of 40 score: 0
Financial ratios for HEVI.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -34090.90909090909
Operating income: -2440151.515151515
Net income: -2237121.212121212
Capital expenditures: 2184090.909090909
Operating cash flow: -262121.2121212121
Depreciation & amortization: 34090.90909090909
Net tangible assets: 8156818.181818182
Owner earnings: -4387121.212121212
Return on net tangible assets (%): -53.78471254759914
Buffett classification: The Gruesome
Stock price: 0.12878787878787878
Shares outstanding: 163013796
Book value: 8156818.181818182
P/B ratio: 2.5738223572025634
Market cap (USD): 20994201
Debt to equity: 0.00399368440605554
Current ratio: 8.877914951989025
Quick ratio: 8.877914951989025
Free cash flow (dilution-adjusted): -2919696.9696969697
Buyback yield (%): 0
Retained earnings: -8884848.484848484
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.52337305224565
Rule of 40 score: 0
Financial ratios for HEVI.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.07407407407407407
Shares outstanding: 163013796
Market cap (USD): 12075096
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEVI.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -15384.615384615385
Operating income: -1102097.9020979023
Net income: -972727.2727272728
Capital expenditures: 1352447.5524475526
Operating cash flow: -509790.20979020983
Depreciation & amortization: 15384.615384615385
Net tangible assets: 6779720.27972028
Owner earnings: -2309790.2097902102
Return on net tangible assets (%): -34.06910778751934
Buffett classification: The Gruesome
Stock price: 0.07692307692307693
Shares outstanding: 163013796
Book value: 6779720.27972028
P/B ratio: 1.8495634409489428
Market cap (USD): 12539522.76923077
Debt to equity: 0.002269210933470861
Current ratio: 5.19893899204244
Quick ratio: 5.19893899204244
Free cash flow (dilution-adjusted): -2015384.6153846155
Buyback yield (%): 0
Retained earnings: -9174125.874125874
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.00487458109069
Rule of 40 score: 0
Financial ratios for HEVI.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.07692307692307693
Shares outstanding: 163013796
Market cap (USD): 12539522.76923077
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEVI.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -3496.5034965034965
Operating income: -485314.68531468534
Net income: -472027.97202797205
Capital expenditures: 1513986.013986014
Operating cash flow: -158041.95804195805
Depreciation & amortization: 3496.5034965034965
Net tangible assets: 7120979.020979022
Owner earnings: -1982517.4825174827
Return on net tangible assets (%): -27.840518511244234
Buffett classification: The Gruesome
Stock price: 0.13286713286713286
Shares outstanding: 163013796
Book value: 7120979.020979021
P/B ratio: 3.041600828832368
Market cap (USD): 21659175.692307692
Debt to equity: 0.0021604635176274184
Current ratio: 2.5228505034856696
Quick ratio: 2.5228505034856696
Free cash flow (dilution-adjusted): -1680419.5804195805
Buyback yield (%): 0
Retained earnings: -9646153.846153846
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.6782140107775225
Rule of 40 score: 0
Financial ratios for HEVI.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -4379.56204379562
Operating income: -159854.01459854015
Net income: -143065.69343065692
Capital expenditures: 3005109.4890510947
Operating cash flow: -272992.700729927
Depreciation & amortization: 4379.56204379562
Net tangible assets: 9799270.0729927
Owner earnings: -3143795.620437956
Return on net tangible assets (%): -32.08193668528864
Buffett classification: The Gruesome
Stock price: 0.1386861313868613
Shares outstanding: 163013796
Book value: 9799270.072992701
P/B ratio: 2.3070853810055865
Market cap (USD): 22607752.729927007
Debt to equity: 0.003575418994413408
Current ratio: 3.746268656716418
Quick ratio: 3.746268656716418
Free cash flow (dilution-adjusted): -3283211.6788321165
Buyback yield (%): 0
Retained earnings: -10211678.832116788
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5998246767477537
Rule of 40 score: 0
Financial ratios for HEVI.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -3597.1223021582737
Operating income: -1125179.856115108
Net income: -1269064.748201439
Capital expenditures: 1080575.5395683453
Operating cash flow: -146762.58992805757
Depreciation & amortization: 3597.1223021582737
Net tangible assets: 8386330.935251799
Owner earnings: -2346043.165467626
Return on net tangible assets (%): -27.974607531955048
Buffett classification: The Gruesome
Stock price: 0.1654676258992806
Shares outstanding: 163013796
Book value: 8386330.935251799
P/B ratio: 3.2163655383031657
Market cap (USD): 26973505.812949646
Debt to equity: 0.7206828515055331
Current ratio: 0.8959252796879812
Quick ratio: 0.8959252796879812
Interest coverage ratio: -39.099999999999994
Free cash flow (dilution-adjusted): -1230215.8273381297
Buyback yield (%): 0.026671522249297978
Retained earnings: -11333812.949640289
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.813370473537603
Rule of 40 score: 0
Financial ratios for HEVI.V — quarterly report dated 2025-12-31
Total revenue: 125547.44525547445
Gross profit: 97810.21897810219
Operating income: -786131.3868613138
Net income: -798540.1459854014
Capital expenditures: 382481.7518248175
Operating cash flow: -312408.7591240876
Depreciation & amortization: 27737.22627737226
Net tangible assets: 13897080.291970802
Owner earnings: -1153284.6715328465
Return on net tangible assets (%): -8.29875518672199
Buffett classification: The Gruesome
Stock price: 0.11678832116788321
Shares outstanding: 163013796
Book value: 13897080.2919708
P/B ratio: 1.36993578234151
Market cap (USD): 19038107.562043793
Debt to equity: 0.0018908556121645045
Current ratio: 5.998396150761828
Quick ratio: 5.998396150761828
COGS to revenue (%): 22.093023255813954
SG&A to revenue (%): 235.46511627906975
Free cash flow (dilution-adjusted): -737226.2773722627
Buyback yield (%): 0
Retained earnings: -12297810.218978101
Receivables turnover: 1.2647058823529413
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.514592933947774
FCF margin (%): -587.2093023255813
Rule of 40 score: -587.2093023255813
Financial ratios for HEVI.V — annual report dated 2025-12-31
Total revenue: 125547.44525547445
Gross profit: 86131.38686131386
Operating income: -2594160.5839416054
Net income: -2721897.8102189777
Capital expenditures: 6064233.576642335
Operating cash flow: -899270.0729927006
Depreciation & amortization: 39416.05839416058
Net tangible assets: 13897080.291970802
Owner earnings: -8746715.328467153
Return on net tangible assets (%): -62.93923000157571
Buffett classification: The Gruesome
Stock price: 0.11678832116788321
Shares outstanding: 163013796
Book value: 13897080.2919708
P/B ratio: 1.36993578234151
Market cap (USD): 19038107.562043793
Debt to equity: 0.0018908556121645045
Current ratio: 5.998396150761828
Quick ratio: 5.998396150761828
Interest coverage ratio: -355.4
COGS to revenue (%): 31.3953488372093
SG&A to revenue (%): 748.8372093023255
Free cash flow (dilution-adjusted): -7022627.737226277
Buyback yield (%): 0
Retained earnings: -12297810.218978101
Receivables turnover: 1.2647058823529413
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.19764464925755
FCF margin (%): -5593.60465116279
Rule of 40 score: -5593.60465116279
Financial ratios for HPS — annual report dated 2021-07-31
Total revenue: 14735670.22
Net income: 109257755
Capital expenditures: 0
Operating cash flow: 27293211
Net tangible assets: 581708301
Owner earnings: 109257755
Return on net tangible assets (%): 18.782223807392427
Buffett classification: The Gruesome
Stock price: 12.62
P/E ratio: 3.7157181732317306
Shares outstanding: 32168861
Book value: 581708301
P/B ratio: 0.697894503348337
Market cap (USD): 405971025.82
Debt to equity: 0.45727385966940154
COGS to revenue (%): 0
SG&A to revenue (%): 3.7203940629447665
Free cash flow (dilution-adjusted): 27293211
Buyback yield (%): 0
Retained earnings: -591323
Receivables turnover: 1.3314253798704145
Capitalized R&D asset: 0
FCF margin (%): 185.2186605191277
Rule of 40 score: 185.2186605191277
Financial ratios for HPS — annual report dated 2022-07-31
Total revenue: -33515741
Net income: -33964251
Capital expenditures: 0
Operating cash flow: 32526468
Net tangible assets: 507072004
Owner earnings: -33964251
Return on net tangible assets (%): -6.698112049585762
Buffett classification: The Gruesome
Stock price: 12.03
Shares outstanding: 32168861
Book value: 507072004
P/B ratio: 0.7631882548775065
Market cap (USD): 386991397.83
Debt to equity: 0.5409488156242205
Free cash flow (dilution-adjusted): 32526468
Buyback yield (%): 0
Retained earnings: -73233930
Receivables turnover: -4.700507374296991
Capitalized R&D asset: 0
Revenue growth (%): -327.44632921080665
Rule of 40 score: -327.44632921080665
Financial ratios for HPS — annual report dated 2023-07-31
Total revenue: -30206762
Net income: -30746321
Capital expenditures: 0
Operating cash flow: 36890143
Net tangible assets: 435753441
Owner earnings: -30746321
Return on net tangible assets (%): -7.0558986130874874
Buffett classification: The Gruesome
Stock price: 11.07
Shares outstanding: 32168861
Book value: 435753441
P/B ratio: 0.8172265730197642
Market cap (USD): 356109291.27
Debt to equity: 0.6294844152475666
Free cash flow (dilution-adjusted): 36890143
Buyback yield (%): 0
Retained earnings: -138860145
Receivables turnover: -2.421023727533902
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HPS — annual report dated 2024-07-31
Total revenue: 66096292
Net income: 65535762
Capital expenditures: 0
Operating cash flow: 44639402
Net tangible assets: 460436616
Owner earnings: 65535762
Return on net tangible assets (%): 14.233394939207006
Buffett classification: The Gruesome
Stock price: 13.67
P/E ratio: 6.710051374240526
Shares outstanding: 32168861
Book value: 460436616
P/B ratio: 0.9550681127193411
Market cap (USD): 439748329.87
Debt to equity: 0.5957388931900238
COGS to revenue (%): 0
SG&A to revenue (%): 0.6078707108108273
Free cash flow (dilution-adjusted): 44639402
Buyback yield (%): 0
Retained earnings: -107436367
Receivables turnover: 5.508191874169506
Capitalized R&D asset: 0
FCF margin (%): 67.53692325130734
Rule of 40 score: 67.53692325130734
Financial ratios for HPS — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 465092935
Buffett classification: The Gruesome
Stock price: 13.18
Shares outstanding: 32168861
Book value: 465092935
P/B ratio: 0.9116147678742959
Market cap (USD): 423985587.98
Debt to equity: 0.5897746006397625
Buyback yield (%): 0
Retained earnings: -103653889
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HPS — annual report dated 2025-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.25
Shares outstanding: 32168861
Market cap (USD): 426237408.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HU3.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.386363636363637
Shares outstanding: 2020414826
Market cap (USD): 29066422383.136364
Buyback yield (%): 2.236257326175492
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HU3.DE — annual report dated 2022-12-31
Total revenue: 7254000000
Net income: 2249000000
Capital expenditures: 1668000000
Operating cash flow: 4027000000
Depreciation & amortization: 484000000
Net tangible assets: 11448000000
Owner earnings: 1065000000
Return on net tangible assets (%): 9.30293501048218
Buffett classification: The Gruesome
Stock price: 13.691489361702128
P/E ratio: 12.299905778748002
Shares outstanding: 2020414826
Book value: 17769000000
P/B ratio: 1.5567836173337979
Market cap (USD): 27662488096.40426
Debt to equity: 0.6449434408239068
Effective tax rate (%): 18.632416787264834
COGS to revenue (%): 0
SG&A to revenue (%): 35.277088502894955
Free cash flow (dilution-adjusted): 3708000000
Buyback yield (%): 0
Retained earnings: 3419000000
Receivables turnover: 1.0710172744721689
Capitalized R&D asset: 0
FCF margin (%): 51.1166253101737
Rule of 40 score: 51.1166253101737
Financial ratios for HU3.DE — annual report dated 2023-12-31
Total revenue: 7360000000
Net income: 1971000000
Capital expenditures: 1751000000
Operating cash flow: 2657000000
Depreciation & amortization: 798000000
Net tangible assets: 13120000000
Owner earnings: 1018000000
Return on net tangible assets (%): 7.759146341463414
Buffett classification: The Gruesome
Shares outstanding: 2020414826
Book value: 19398000000
Debt to equity: 0.6390349520569131
Effective tax rate (%): 17.323825503355707
COGS to revenue (%): 0
SG&A to revenue (%): 40.02717391304348
Free cash flow (dilution-adjusted): 2420000000
Retained earnings: 4322000000
Receivables turnover: 1.0782302959273367
Capitalized R&D asset: 0
FCF margin (%): 32.880434782608695
Revenue growth (%): 1.4612627515853323
Rule of 40 score: 34.341697534194026
Financial ratios for HU3.DE — annual report dated 2024-12-31
Total revenue: 7385000000
Net income: 1960000000
Capital expenditures: 1626000000
Operating cash flow: 1836000000
Depreciation & amortization: 622000000
Net tangible assets: 13502000000
Owner earnings: 956000000
Return on net tangible assets (%): 7.080432528514294
Buffett classification: The Gruesome
Shares outstanding: 2020414826
Book value: 19782000000
Debt to equity: 0.8306035790112223
Effective tax rate (%): 18.435289221806077
COGS to revenue (%): 0
SG&A to revenue (%): 39.688557887610024
Free cash flow (dilution-adjusted): 1587000000
Retained earnings: 5204000000
Receivables turnover: 0.9742744063324539
Capitalized R&D asset: 0
FCF margin (%): 21.489505754908595
Revenue growth (%): 0.33967391304347827
Rule of 40 score: 21.829179667952072
Financial ratios for HU3.DE — quarterly report dated 2025-03-31
Total revenue: 1920000000
Net income: 531000000
Capital expenditures: 54000000
Operating cash flow: 513000000
Depreciation & amortization: 209000000
Net tangible assets: 14217000000
Owner earnings: 686000000
Return on net tangible assets (%): 4.8252092565238796
Buffett classification: The Gruesome
Shares outstanding: 2020414826
Book value: 20486000000
Debt to equity: 0.9093039148686908
Effective tax rate (%): 18.68300153139357
COGS to revenue (%): 0
SG&A to revenue (%): 38.385416666666664
Free cash flow (dilution-adjusted): 438000000
Retained earnings: 5474000000
Receivables turnover: 0.2701561840439004
Capitalized R&D asset: 0
FCF margin (%): 22.8125
Rule of 40 score: 22.8125
Financial ratios for HU3.DE — quarterly report dated 2025-06-30
Total revenue: 1938000000
Net income: 542000000
Capital expenditures: 686000000
Operating cash flow: 554000000
Depreciation & amortization: 188000000
Net tangible assets: 14720000000
Owner earnings: 44000000
Return on net tangible assets (%): 0.29891304347826086
Buffett classification: The Gruesome
Shares outstanding: 2020414826
Book value: 20970000000
Debt to equity: 0.8541726275631855
Effective tax rate (%): 15.047021943573668
COGS to revenue (%): 0
SG&A to revenue (%): 39.73168214654283
Free cash flow (dilution-adjusted): 468000000
Retained earnings: 5751000000
Receivables turnover: 0.2718855218855219
Capitalized R&D asset: 0
FCF margin (%): 24.148606811145513
Revenue growth (%): 0.9375
Rule of 40 score: 25.086106811145513
Financial ratios for HU3.DE — quarterly report dated 2025-09-30
Total revenue: 2134000000
Net income: 633000000
Capital expenditures: 41000000
Operating cash flow: 487000000
Depreciation & amortization: 175000000
Net tangible assets: 16057000000
Owner earnings: 767000000
Return on net tangible assets (%): 4.776732889082643
Buffett classification: The Gruesome
Stock price: 16.88235294117647
P/E ratio: 19.993760949658647
Shares outstanding: 2020414826
Book value: 22286000000
P/B ratio: 1.5305284115641054
Market cap (USD): 34109356180.11765
Debt to equity: 0.781791259086422
Effective tax rate (%): 17.362924281984334
COGS to revenue (%): 0
SG&A to revenue (%): 37.488284910965326
Free cash flow (dilution-adjusted): 415000000
Buyback yield (%): 0
Retained earnings: 6123000000
Receivables turnover: 0.29357545742192875
Capitalized R&D asset: 0
FCF margin (%): 19.44704779756326
Revenue growth (%): 10.113519091847266
Rule of 40 score: 29.560566889410527
Financial ratios for HU3.DE — annual report dated 2025-12-31
Total revenue: 8131000000
Net income: 2229000000
Capital expenditures: 1589000000
Operating cash flow: 2482000000
Depreciation & amortization: 762000000
Net tangible assets: 17593000000
Owner earnings: 1402000000
Return on net tangible assets (%): 7.969078610811119
Buffett classification: The Gruesome
Stock price: 17.36470588235294
P/E ratio: 15.739752899881243
Shares outstanding: 2020414826
Book value: 24379000000
P/B ratio: 1.439103704575056
Market cap (USD): 35083909213.83529
Debt to equity: 0.7572090733828295
Effective tax rate (%): 17.075892857142858
COGS to revenue (%): 0
SG&A to revenue (%): 38.53154593530931
Free cash flow (dilution-adjusted): 2102000000
Buyback yield (%): 0
Retained earnings: 6351000000
Receivables turnover: 0.984859496124031
Capitalized R&D asset: 0
FCF margin (%): 25.851678760300086
Revenue growth (%): 10.10155721056195
Rule of 40 score: 35.95323597086204
Financial ratios for HU3.DE — quarterly report dated 2025-12-31
Total revenue: 2139000000
Net income: 523000000
Capital expenditures: 1738000000
Operating cash flow: 928000000
Depreciation & amortization: 190000000
Net tangible assets: 17593000000
Owner earnings: -1025000000
Return on net tangible assets (%): -5.826180867390439
Buffett classification: The Gruesome
Stock price: 17.36470588235294
P/E ratio: 15.739752899881243
Shares outstanding: 2020414826
Book value: 24379000000
P/B ratio: 1.439103704575056
Market cap (USD): 35083909213.83529
Debt to equity: 0.7572090733828295
Effective tax rate (%): 17.11568938193344
COGS to revenue (%): 0
SG&A to revenue (%): 38.61617578307621
Free cash flow (dilution-adjusted): 781000000
Buyback yield (%): 0
Retained earnings: 6351000000
Receivables turnover: 0.2590843023255814
Capitalized R&D asset: 0
FCF margin (%): 36.51238896680692
Revenue growth (%): 0.23430178069353325
Rule of 40 score: 36.74669074750045
Financial ratios for IBRX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.08
Shares outstanding: 1047353977
Market cap (USD): 6367912180.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBRX — annual report dated 2022-12-31
Total revenue: 240000
Gross profit: 240000
Operating income: -350617000
Net income: -416567000
Capital expenditures: 78162000
Operating cash flow: -337509000
Depreciation & amortization: 18260000
Net tangible assets: -467330000
Owner earnings: -476469000
Buffett classification: The Gruesome
Stock price: 5.07
Shares outstanding: 1047353977
Book value: -449820000
Market cap (USD): 5310084663.39
Debt to equity: -1.6090280556667111
Current ratio: 0.28067068508029175
Quick ratio: 0.28067068508029175
Interest coverage ratio: -7.43699225792767
COGS to revenue (%): 0
R&D to revenue (%): 103395.41666666667
SG&A to revenue (%): 42795
Free cash flow (dilution-adjusted): -477079000
Buyback yield (%): 0
Retained earnings: -2378488000
Receivables turnover: 0.12698412698412698
Capitalized R&D asset: 248149000
ROCI (R&D-adjusted, %): -168.89600282125178
FCF margin (%): -198782.91666666666
Rule of 40 score: -198782.91666666666
Financial ratios for IBRX — annual report dated 2023-12-31
Total revenue: 622000
Gross profit: 622000
Operating income: -361364000
Net income: -583196000
Capital expenditures: 30584000
Operating cash flow: -366757000
Depreciation & amortization: 18512000
Net tangible assets: -604080000
Owner earnings: -595268000
Buffett classification: The Gruesome
Stock price: 5.02
Shares outstanding: 1047353977
Book value: -585937000
Market cap (USD): 5257716964.54
Debt to equity: -1.2402749783679816
Current ratio: 5.045793799221042
Quick ratio: 5.045793799221042
Interest coverage ratio: -4.163035839775123
COGS to revenue (%): 0
R&D to revenue (%): 37357.87781350483
SG&A to revenue (%): 20839.228295819936
Free cash flow (dilution-adjusted): -446504000
Buyback yield (%): 0
Retained earnings: -2961684000
Receivables turnover: 0.19633838383838384
Capitalized R&D asset: 398625830
ROCI (R&D-adjusted, %): -34.22957342987843
Rosenberg metric: 0.0015393977005750577
FCF margin (%): -71785.20900321544
Revenue growth (%): 159.16666666666666
Rule of 40 score: -71626.04233654877
Financial ratios for IBRX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.72
Shares outstanding: 1047353977
Market cap (USD): 3896156794.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBRX — annual report dated 2024-12-31
Total revenue: 14745000
Gross profit: 14745000
Operating income: -344182000
Net income: -413564000
Capital expenditures: 6888000
Operating cash flow: -391236000
Depreciation & amortization: 17554000
Net tangible assets: -505031000
Owner earnings: -402898000
Buffett classification: The Gruesome
Stock price: 2.56
Shares outstanding: 1047353977
Book value: -488129000
Market cap (USD): 2681226181.12
Debt to equity: -1.032854020146314
Current ratio: 3.359529702970297
Quick ratio: 3.208976412347117
Interest coverage ratio: -2.6125853954759375
COGS to revenue (%): 0
R&D to revenue (%): 1289.5489996609022
SG&A to revenue (%): 1144.679552390641
Free cash flow (dilution-adjusted): -432556000
Buyback yield (%): 0
Retained earnings: -3375248000
Inventory turnover: 0
Receivables turnover: 5.557859027516019
Capitalized R&D asset: 427718390
ROCI (R&D-adjusted, %): -49.9652385296907
Rosenberg metric: 0.0607791157053958
FCF margin (%): -2933.577483892845
Revenue growth (%): 2270.578778135048
Rule of 40 score: -662.9987057577969
Financial ratios for IBRX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.56
Shares outstanding: 1047353977
Market cap (USD): 2681226181.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBRX — quarterly report dated 2025-03-31
Total revenue: 16517000
Gross profit: 16459000
Operating income: -64429000
Net income: -129646000
Capital expenditures: 1121000
Operating cash flow: -85905000
Depreciation & amortization: 3829000
Net tangible assets: -606874000
Owner earnings: -126938000
Buffett classification: The Gruesome
Stock price: 3.01
Shares outstanding: 1047353977
Book value: -590482000
Market cap (USD): 3152535470.77
Debt to equity: -0.8912617150057072
Current ratio: 2.2185347017579513
Quick ratio: 2.0469261253937607
Interest coverage ratio: -2.2320803741555517
COGS to revenue (%): 0.35115335714718166
R&D to revenue (%): 292.0263970454683
SG&A to revenue (%): 197.69934007386328
Free cash flow (dilution-adjusted): -96563000
Buyback yield (%): 0
Retained earnings: -3504894000
Inventory turnover: 0.006868782567503553
Receivables turnover: 0.9463702515326878
Capitalized R&D asset: 48234000
ROCI (R&D-adjusted, %): -10.658612626656275
FCF margin (%): -584.6279590724708
Rule of 40 score: -584.6279590724708
Financial ratios for IBRX — quarterly report dated 2025-06-30
Total revenue: 26425000
Gross profit: 26289000
Operating income: -71285000
Net income: -92555000
Capital expenditures: 1081000
Operating cash flow: -79746000
Depreciation & amortization: 3880000
Net tangible assets: -585726000
Owner earnings: -89756000
Buffett classification: The Gruesome
Stock price: 2.64
Shares outstanding: 1047353977
Book value: -569819000
Market cap (USD): 2765014499.28
Debt to equity: -0.9394491935158358
Current ratio: 4.109706974172656
Quick ratio: 3.978595687544428
Interest coverage ratio: -2.4679753496745604
COGS to revenue (%): 0.5146641438032167
R&D to revenue (%): 209.02932828760643
SG&A to revenue (%): 160.2194891201514
Free cash flow (dilution-adjusted): -90475000
Buyback yield (%): 0
Retained earnings: -3597449000
Inventory turnover: 0.020481927710843374
Receivables turnover: 1.183385579937304
Capitalized R&D asset: 87552780
ROCI (R&D-adjusted, %): -11.512699825265013
Rosenberg metric: 0.20379815068209148
FCF margin (%): -342.3841059602649
Revenue growth (%): 59.986680389901316
Rule of 40 score: -282.39742557036357
Financial ratios for IBRX — quarterly report dated 2025-09-30
Total revenue: 32061000
Gross profit: 31884000
Operating income: -55630000
Net income: -67253000
Capital expenditures: 741000
Operating cash flow: -68907000
Depreciation & amortization: 3951000
Net tangible assets: -538794000
Owner earnings: -64043000
Buffett classification: The Gruesome
Stock price: 2.46
Shares outstanding: 1047353977
Book value: -523410000
Market cap (USD): 2576490783.42
Debt to equity: -1.035994726887144
Current ratio: 5.767091399166871
Quick ratio: 5.649770714460741
Interest coverage ratio: -2.0167488399071924
COGS to revenue (%): 0.5520726115841676
R&D to revenue (%): 159.79539003774056
SG&A to revenue (%): 113.16552821184618
Free cash flow (dilution-adjusted): -78560000
Buyback yield (%): 0
Retained earnings: -3664702000
Inventory turnover: 0.026406086826793972
Receivables turnover: 0.9508853100809681
Capitalized R&D asset: 104157340
ROCI (R&D-adjusted, %): -9.887687446369501
Rosenberg metric: 0.10129263523788834
FCF margin (%): -245.03290602289388
Revenue growth (%): 21.328287606433303
Rule of 40 score: -223.7046184164606
Financial ratios for IBRX — quarterly report dated 2025-12-31
Total revenue: 38285000
Gross profit: 37903000
Operating income: -64683000
Net income: -61944000
Capital expenditures: 903000
Operating cash flow: -70378000
Depreciation & amortization: 3865000
Net tangible assets: -514422000
Owner earnings: -58982000
Buffett classification: The Gruesome
Stock price: 1.98
Shares outstanding: 1047353977
Book value: -499574000
Market cap (USD): 2073760874.46
Debt to equity: -1.037033552586804
Current ratio: 5.098859992874956
Quick ratio: 5.084124105321113
Interest coverage ratio: -2.3787511032656665
COGS to revenue (%): 0.9977798093248008
R&D to revenue (%): 166.79378346610946
SG&A to revenue (%): 101.15972312916286
Free cash flow (dilution-adjusted): -80399000
Buyback yield (%): 0
Retained earnings: -3726646000
Inventory turnover: 0.4197802197802198
Receivables turnover: 0.8983504235399019
Capitalized R&D asset: 116410320
ROCI (R&D-adjusted, %): -10.349573784639746
Rosenberg metric: 0.11748516552154903
FCF margin (%): -210.0013059945148
Revenue growth (%): 19.412993980225195
Rule of 40 score: -190.5883120142896
Financial ratios for IBRX — annual report dated 2025-12-31
Total revenue: 113288000
Gross profit: 112535000
Operating income: -256027000
Net income: -351398000
Capital expenditures: 3846000
Operating cash flow: -304936000
Depreciation & amortization: 15525000
Net tangible assets: -514422000
Owner earnings: -339719000
Buffett classification: The Gruesome
Stock price: 1.98
Shares outstanding: 1047353977
Book value: -499574000
Market cap (USD): 2073760874.46
Debt to equity: -1.037033552586804
Current ratio: 5.098859992874956
Quick ratio: 5.084124105321113
Interest coverage ratio: -2.2752899355698735
COGS to revenue (%): 0.6646776357601863
R&D to revenue (%): 192.9233458089118
SG&A to revenue (%): 132.4085516559565
Free cash flow (dilution-adjusted): -345997000
Buyback yield (%): 0
Retained earnings: -3726646000
Inventory turnover: 0.8274725274725274
Receivables turnover: 2.658281906281531
Capitalized R&D asset: 422636260
ROCI (R&D-adjusted, %): -29.110270402647675
Rosenberg metric: 0.5142944294850219
FCF margin (%): -305.41363604265234
Revenue growth (%): 668.3146829433706
Rule of 40 score: 362.90104690071826
Financial ratios for IONS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.43
Shares outstanding: 165262556
Market cap (USD): 5028939579.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IONS — annual report dated 2022-12-31
Total revenue: 587367000
Gross profit: 573251000
Operating income: -410191000
Net income: -269722000
Capital expenditures: 15721000
Operating cash flow: -274370000
Depreciation & amortization: 22105000
Net tangible assets: 572887000
Owner earnings: -263338000
Return on net tangible assets (%): -45.96683115518418
Buffett classification: The Gruesome
Stock price: 37.77
Shares outstanding: 165262556
Book value: 572887000
P/B ratio: 10.895633414827008
Market cap (USD): 6241966740.120001
Debt to equity: 2.3899913944634807
Current ratio: 7.069864328333777
Quick ratio: 6.999146234605743
Interest coverage ratio: -50.50369367150948
COGS to revenue (%): 2.4032674631022855
R&D to revenue (%): 141.8443664693454
SG&A to revenue (%): 25.588771585737707
Free cash flow (dilution-adjusted): -394733000
Buyback yield (%): 0
Retained earnings: -1429625000
Inventory turnover: 0.640675350610448
Receivables turnover: 22.99972589866082
Capitalized R&D asset: 833147000
ROCI (R&D-adjusted, %): 4.753465542472245
FCF margin (%): -67.20380954326681
Rule of 40 score: -67.20380954326681
Financial ratios for IONS — annual report dated 2023-12-31
Total revenue: 787647000
Gross profit: 778514000
Operating income: -353730000
Net income: -366286000
Capital expenditures: 23805000
Operating cash flow: -307513000
Depreciation & amortization: 22498000
Net tangible assets: 386686000
Owner earnings: -367593000
Return on net tangible assets (%): -95.06240205231119
Buffett classification: The Gruesome
Stock price: 50.59
Shares outstanding: 165262556
Book value: 386686000
P/B ratio: 21.621244906823623
Market cap (USD): 8360632708.040001
Debt to equity: 3.758964637974998
Current ratio: 5.895808877680823
Quick ratio: 5.879202838715437
Interest coverage ratio: -4.342536553027978
COGS to revenue (%): 1.15952958622327
R&D to revenue (%): 114.21677477347086
SG&A to revenue (%): 29.533407732143967
Free cash flow (dilution-adjusted): -441311000
Buyback yield (%): 0
Retained earnings: -1795911000
Inventory turnover: 1.2273887918290551
Receivables turnover: 8.05546237394915
Capitalized R&D asset: 1457833490
ROCI (R&D-adjusted, %): -0.792428219399356
Rosenberg metric: 0.24637068848594545
FCF margin (%): -56.02903331060741
Revenue growth (%): 34.09793195736226
Rule of 40 score: -21.931101353245147
Financial ratios for IONS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.06
Shares outstanding: 165262556
Market cap (USD): 6620417993.360001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IONS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.96
Shares outstanding: 165262556
Market cap (USD): 5777578957.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IONS — annual report dated 2024-12-31
Total revenue: 705138000
Gross profit: 693923000
Operating income: -475107000
Net income: -453897000
Capital expenditures: 45280000
Operating cash flow: -500947000
Depreciation & amortization: 21990000
Net tangible assets: 588351000
Owner earnings: -477187000
Return on net tangible assets (%): -81.105836481964
Buffett classification: The Gruesome
Stock price: 34.96
Shares outstanding: 165262556
Book value: 588351000
P/B ratio: 9.819952643507023
Market cap (USD): 5777578957.76
Debt to equity: 2.4076937066479025
Current ratio: 8.471184994083758
Quick ratio: 8.430734713143108
Interest coverage ratio: -5.632099292293467
COGS to revenue (%): 1.5904688160331737
R&D to revenue (%): 127.85156948001668
SG&A to revenue (%): 37.93583667310512
Free cash flow (dilution-adjusted): -681488000
Buyback yield (%): 0
Retained earnings: -2249808000
Inventory turnover: 0.8963395140664961
Receivables turnover: 7.648913090640864
Capitalized R&D asset: 1779217260
ROCI (R&D-adjusted, %): -10.096572458968561
Rosenberg metric: -0.09402917882451022
FCF margin (%): -96.64604658946192
Revenue growth (%): -10.475377929453169
Rule of 40 score: -107.12142451891509
Financial ratios for IONS — quarterly report dated 2025-03-31
Total revenue: 131612000
Gross profit: 130112000
Operating income: -146947000
Net income: -146938000
Capital expenditures: 12577000
Operating cash flow: -150775000
Depreciation & amortization: 5397000
Net tangible assets: 475726000
Owner earnings: -154118000
Return on net tangible assets (%): -32.396379428494555
Buffett classification: The Gruesome
Stock price: 30.17
Shares outstanding: 165262556
Book value: 475726000
P/B ratio: 10.480762696426094
Market cap (USD): 4985971314.52
Debt to equity: 2.9641222047985605
Current ratio: 9.664401321651026
Quick ratio: 9.618447179905152
Interest coverage ratio: -6.859630286621231
COGS to revenue (%): 1.139713703917576
R&D to revenue (%): 152.5385223231924
SG&A to revenue (%): 57.97343707260736
Free cash flow (dilution-adjusted): -193721000
Buyback yield (%): 0
Retained earnings: -2396746000
Inventory turnover: 0.13041210224308816
Receivables turnover: 3.3145792933235954
Capitalized R&D asset: 200759000
ROCI (R&D-adjusted, %): -0.4743287349150965
FCF margin (%): -147.19098562441116
Rule of 40 score: -147.19098562441116
Financial ratios for IONS — quarterly report dated 2025-06-30
Total revenue: 452049000
Gross profit: 447898000
Operating income: 139838000
Net income: 123551000
Capital expenditures: 12305000
Operating cash flow: 151338000
Depreciation & amortization: 5454000
Net tangible assets: 631724000
Owner earnings: 116700000
Return on net tangible assets (%): 18.473257308571466
Capex to operating income (%): 8.7994679557774
Buffett classification: The Great
Stock price: 39.51
P/E ratio: 13.212203032674765
Shares outstanding: 165262556
Book value: 631724000
P/B ratio: 10.336038503460372
Market cap (USD): 6529523587.559999
Debt to equity: 2.247802837948218
Current ratio: 2.8723212176060704
Quick ratio: 2.862868855016963
Effective tax rate (%): -0.016190268029887232
Interest coverage ratio: 6.581231174698795
COGS to revenue (%): 0.9182632856172672
R&D to revenue (%): 48.105404502609225
SG&A to revenue (%): 20.042075084780635
Free cash flow (dilution-adjusted): 107379000
Buyback yield (%): 0
Retained earnings: -2273195000
Inventory turnover: 0.48944699917462564
Receivables turnover: 8.597356409281096
Capitalized R&D asset: 351968530
ROCI (R&D-adjusted, %): 8.930478503324183
Rosenberg metric: 1.582922807943853
FCF margin (%): 23.75384084468719
Revenue growth (%): 243.47096009482416
Rule of 40 score: 267.22480093951134
Financial ratios for IONS — quarterly report dated 2025-09-30
Total revenue: 156719000
Gross profit: 154381000
Operating income: -160173000
Net income: -128606000
Capital expenditures: 5270000
Operating cash flow: -131437000
Depreciation & amortization: 4502000
Net tangible assets: 617967000
Owner earnings: -129374000
Return on net tangible assets (%): -20.93542211800954
Buffett classification: The Gruesome
Stock price: 65.42
Shares outstanding: 165262556
Book value: 617967000
P/B ratio: 17.495232615204372
Market cap (USD): 10811476413.52
Debt to equity: 2.410308317434426
Current ratio: 2.7881745209506605
Quick ratio: 2.776585688733043
Interest coverage ratio: -7.793548073180226
COGS to revenue (%): 1.4918420867922844
R&D to revenue (%): 138.94550118364717
SG&A to revenue (%): 61.76660136932982
Free cash flow (dilution-adjusted): -169513000
Buyback yield (%): 0
Retained earnings: -2401801000
Inventory turnover: 0.2233046800382044
Receivables turnover: 6.368619960988297
Capitalized R&D asset: 429702670
ROCI (R&D-adjusted, %): -6.033201550930949
Rosenberg metric: -1.3497516784696035
FCF margin (%): -108.16365597023973
Revenue growth (%): -65.33141318750843
Rule of 40 score: -173.49506915774816
Financial ratios for IONS — quarterly report dated 2025-12-31
Total revenue: 203330000
Gross profit: 195373000
Operating income: -214473000
Net income: -229394000
Capital expenditures: 21292000
Operating cash flow: -137709000
Depreciation & amortization: 7341000
Net tangible assets: 489089000
Owner earnings: -243345000
Return on net tangible assets (%): -49.754748113329065
Buffett classification: The Gruesome
Stock price: 79.11
Shares outstanding: 165262556
Book value: 489089000
P/B ratio: 26.7311691842589
Market cap (USD): 13073920805.16
Debt to equity: 4.221137666150741
Current ratio: 3.8264601755191814
Quick ratio: 3.813603952060412
Interest coverage ratio: -10.183903133903135
COGS to revenue (%): 3.9133428416859295
R&D to revenue (%): 137.53307431269366
SG&A to revenue (%): 64.03383662027247
Free cash flow (dilution-adjusted): -203686000
Buyback yield (%): 0
Retained earnings: -2631195000
Inventory turnover: 0.7918988853503185
Receivables turnover: 3.0780060249171197
Capitalized R&D asset: 497302980
ROCI (R&D-adjusted, %): -5.343720335137195
Rosenberg metric: 0.18824912515958375
FCF margin (%): -100.17508483745634
Revenue growth (%): 29.74176711183711
Rule of 40 score: -70.43331772561923
Financial ratios for IONS — annual report dated 2025-12-31
Total revenue: 943711000
Gross profit: 927802000
Operating income: -381717000
Net income: -381387000
Capital expenditures: 51444000
Operating cash flow: -268583000
Depreciation & amortization: 22694000
Net tangible assets: 489089000
Owner earnings: -410137000
Return on net tangible assets (%): -83.85733475911337
Buffett classification: The Gruesome
Stock price: 79.11
Shares outstanding: 165262556
Book value: 489089000
P/B ratio: 26.7311691842589
Market cap (USD): 13073920805.16
Debt to equity: 4.221137666150741
Current ratio: 3.8264601755191814
Quick ratio: 3.813603952060412
Interest coverage ratio: -4.5290453477610875
COGS to revenue (%): 1.6857915188018366
R&D to revenue (%): 97.02324122533275
SG&A to revenue (%): 41.739473207369635
Free cash flow (dilution-adjusted): -459541000
Buyback yield (%): 0
Retained earnings: -2631195000
Inventory turnover: 1.5833001592356688
Receivables turnover: 14.285880803524122
Capitalized R&D asset: 1816520350
ROCI (R&D-adjusted, %): -8.153246504652236
Rosenberg metric: 0.25942453384801395
FCF margin (%): -48.69509839347003
Revenue growth (%): 33.83351911257087
Rule of 40 score: -14.861579280899164
Financial ratios for KMR.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.045000000000000005
Shares outstanding: 88648620
Market cap (USD): 3989187.9000000004
Buyback yield (%): 2324.1515579467373
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KMR.L — annual report dated 2022-12-31
Total revenue: 559561702.1276596
Gross profit: 258823404.25531918
Operating income: 248331914.89361703
Net income: 219185106.38297874
Capital expenditures: 63688297.872340426
Operating cash flow: 222629787.23404256
Depreciation & amortization: 68719148.93617022
Net tangible assets: 1173972340.4255319
Owner earnings: 224215957.44680852
Return on net tangible assets (%): 19.098913128186357
Capex to operating income (%): 25.6464409335481
Buffett classification: The Good
Stock price: 0.04024096385542169
P/E ratio: 0.016275311640107128
Shares outstanding: 88648620
Book value: 1173972340.4255319
P/B ratio: 0.0030386626587471086
Market cap (USD): 3567305.913253012
Debt to equity: 0.07282331128900424
Current ratio: 4.066198106055739
Quick ratio: 2.9846839785678494
Effective tax rate (%): 7.236602178229412
Interest coverage ratio: 24.015637860082307
COGS to revenue (%): 53.745332593139004
SG&A to revenue (%): 1.8749477174384206
Free cash flow (dilution-adjusted): 152982978.72340426
Buyback yield (%): 15.358154129426186
Retained earnings: 345447872.34042555
Inventory turnover: 3.358567677703722
Receivables turnover: 5.010841192721729
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.93441502988898
FCF margin (%): 27.339787219480293
Rule of 40 score: 27.339787219480293
Financial ratios for KMR.L — annual report dated 2023-12-31
Total revenue: 509418888.8888889
Gross profit: 181722222.2222222
Operating income: 172360000
Net income: 145535555.55555555
Capital expenditures: 73933333.33333333
Operating cash flow: 170216666.66666666
Depreciation & amortization: 72357777.77777778
Net tangible assets: 1270323333.3333333
Owner earnings: 143960000
Return on net tangible assets (%): 11.332547881510482
Capex to operating income (%): 42.89471648487661
Buffett classification: The Good
Stock price: 0.0420253164556962
P/E ratio: 0.025598461452525412
Shares outstanding: 88648620
Book value: 1270323333.3333335
P/B ratio: 0.0029327071392800984
Market cap (USD): 3725486.3088607597
Debt to equity: 0.04320247426070877
Current ratio: 4.037073960994455
Quick ratio: 2.800149542027541
Effective tax rate (%): 12.626242412113935
Interest coverage ratio: 17.783331422675687
COGS to revenue (%): 64.32754532942765
SG&A to revenue (%): 1.8378239257367326
Free cash flow (dilution-adjusted): 92641111.1111111
Buyback yield (%): 893.6342657612091
Retained earnings: 408337777.7777778
Inventory turnover: 2.971347109020019
Receivables turnover: 3.5975345647431776
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.135793436675963
FCF margin (%): 18.185645081432654
Revenue growth (%): -8.961087409683191
Rule of 40 score: 9.224557671749462
Financial ratios for KMR.L — annual report dated 2024-12-31
Total revenue: 432028125
Gross profit: 99350000
Operating income: 92933333.33333334
Net income: 67594791.66666667
Capital expenditures: 158948958.33333334
Operating cash flow: 166489583.33333334
Depreciation & amortization: 70801041.66666667
Net tangible assets: 1209462500
Owner earnings: -20553125
Return on net tangible assets (%): -1.6993602530049505
Capex to operating income (%): 171.03546449067431
Buffett classification: The Gruesome
Stock price: 0.037625
P/E ratio: 0.049344102485706795
Shares outstanding: 88648620
Book value: 1209462500.0000002
P/B ratio: 0.0027577575389894264
Market cap (USD): 3335404.3274999997
Debt to equity: 0.0682525984338773
Current ratio: 5.891507327568709
Quick ratio: 3.6019770226931356
Effective tax rate (%): 20.93213110759108
Interest coverage ratio: 18.945848375451263
COGS to revenue (%): 77.0038119624735
SG&A to revenue (%): 1.4852428106773528
Free cash flow (dilution-adjusted): 3807291.6666666665
Buyback yield (%): 0
Retained earnings: 401836458.3333334
Inventory turnover: 2.8314035958721937
Receivables turnover: 4.53518277547539
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.080337096931637
FCF margin (%): 0.8812601417249553
Revenue growth (%): -15.191969826185392
Rule of 40 score: -14.310709684460438